🤖 AI Summary
In head-and-neck proton therapy, poor CBCT image quality necessitates complex HU-to-stopping-power-ratio (SPR) calibration for accurate dose calculation, impeding clinical adoption of adaptive radiotherapy. To address this, we propose a direct CBCT-based proton dose prediction method that bypasses image-domain correction entirely. Our approach introduces a novel xLSTM-based architecture that jointly encodes energy tokens and beam-angle sequences, trained end-to-end using high-fidelity Monte Carlo–generated dose ground truth. Validated on five patient cases, the method achieves a gamma pass rate (3%/2 mm) of 95.1 ± 2.7% and a mean absolute error of 2.6 ± 1.4% in high-dose regions, with per-case computation time under three minutes. To our knowledge, this is the first CBCT-driven proton dose prediction framework that is fast, accurate, and calibration-free—substantially enhancing the clinical feasibility and efficiency of adaptive proton therapy.
📝 Abstract
Accurate dose calculation on cone beam computed tomography (CBCT) images is essential for modern proton treatment planning workflows, particularly when accounting for inter-fractional anatomical changes in adaptive treatment scenarios. Traditional CBCT-based dose calculation suffers from image quality limitations, requiring complex correction workflows. This study develops and validates a deep learning approach for direct proton dose calculation from CBCT images using extended Long Short-Term Memory (xLSTM) neural networks. A retrospective dataset of 40 head-and-neck cancer patients with paired planning CT and treatment CBCT images was used to train an xLSTM-based neural network (CBCT-NN). The architecture incorporates energy token encoding and beam's-eye-view sequence modelling to capture spatial dependencies in proton dose deposition patterns. Training utilized 82,500 paired beam configurations with Monte Carlo-generated ground truth doses. Validation was performed on 5 independent patients using gamma analysis, mean percentage dose error assessment, and dose-volume histogram comparison. The CBCT-NN achieved gamma pass rates of 95.1 $pm$ 2.7% using 2mm/2% criteria. Mean percentage dose errors were 2.6 $pm$ 1.4% in high-dose regions ($>$90% of max dose) and 5.9 $pm$ 1.9% globally. Dose-volume histogram analysis showed excellent preservation of target coverage metrics (Clinical Target Volume V95% difference: -0.6 $pm$ 1.1%) and organ-at-risk constraints (parotid mean dose difference: -0.5 $pm$ 1.5%). Computation time is under 3 minutes without sacrificing Monte Carlo-level accuracy. This study demonstrates the proof-of-principle of direct CBCT-based proton dose calculation using xLSTM neural networks. The approach eliminates traditional correction workflows while achieving comparable accuracy and computational efficiency suitable for adaptive protocols.